A delayed-type hypersensitivity (DTH) Brucellosis is a zoonotic disease of great public health and economic importance throughout the world (14). Control of the disease depends on the one hand on the ability to identify and remove contaminated animals and on the other hand on prophylactic measures such as vaccination. Identification of brucella infections in animals is based mainly on serological tests. These tests are sensitive and specific, but they are difficult to perform under field conditions (12, 13).
Brucellosis is a zoonotic disease of great public health and economic importance throughout the world (14) . Control of the disease depends on the one hand on the ability to identify and remove contaminated animals and on the other hand on prophylactic measures such as vaccination. Identification of brucella infections in animals is based mainly on serological tests. These tests are sensitive and specific, but they are difficult to perform under field conditions (12, 13) .
As a facultative intracellular pathogen, a brucella elicits a cellular immune response as well as an antibody response. Delayed-type hypersensitivity (DTH) is one of the expressions of cellular immunity. This reaction can be measured in sensitized animals by the swelling and the erythema resulting from the intradermal injection of the pathogen's allergenic antigens (15, 17, 24) .
A skin test to detect DTH and identify brucella-contaminated animals is used widely. However, the use of this test is limited to surveillance of whole herds and does not extend to the detection of the exposure of individual animals in a herd to the pathogen. This is because of the lower sensitivity of the skin test (60 to 80% sensitivity) compared with that of the conventional serum tube agglutination test (80 to 85% sensitivity) and that of the complement fixation test or the Rose Bengal test, which both have 90 to 95% sensitivities (12) . Nevertheless, the specificity of the skin test is superior to that of the seroagglutination test and equal to that of the complement fixation test (14, 27) . Brucella protein preparations (such as brucellin INRA, also called Brucellergen) have proved to be able to reveal a DTH reaction in sensitized animals (14) . The protein composition of these preparations has been poorly characterized (18) . Brucellergen is composed of 20 to 30 proteins. Only one fraction, composed of at least 3 not functionally defined proteins each with a molecular weight of 3 x 104, has been shown to be immunogenic in the DTH reaction (7) . For the reasons stated above, the standardization of the existing skin test has not been yet achieved. Recombinant brucella-allergenic proteins could be good candidates for use in a skin test that could be standardized. In addition, the use of recombinant proteins would reduce the risks due to exposure to brucella during production of such reagents.
Filters bearing a 12-kDa protein isolated from Brucella abortus were able to reveal a DTH reaction in sensitized guinea pigs (5) . This protein was characterized as an immunodominant protein by Brooks-Worrell and Splitter using a T-lymphocyte Western blot (immunoblot) technique (9) . The N-terminal amino acid sequence of this protein was reported by BrooksWorrell and Splitter (10) . An oligonucleotide corresponding to the N-terminal amino acid sequence of the B. abortus 12-kDa protein was used as a probe to screen a Brucella melitensis genomic library. The gene encoding the 12-kDa B. melitensis protein was identified, sequenced, and found to be similar to the Escherichia coli ribosomal protein L7/L12 (2) and identical to the B. abortus L7/L12 protein (22) .
In the work presented here, we describe the isolation and the identification of the brucella L7/L12 protein from brucellin INRA (Brucellergen). We also characterize the antigenic properties of this protein in the DTH reaction of brucellasensitized guinea pigs.
MATERUILS AND METHODS
Bacterial strains and DNA preparation. B. melitensis Revl, B115, and 16M were grown on tryptic soy agar supplemented with glucose serum (1) . The strains were from freeze-dried bacterial stocks maintained at the Israeli Brucellosis Reference Center, Kimron Veterinary Institute. The DNA of strain 16M was isolated as previously described (6 Samples (10 ,u) from each fraction were loaded on SDS-15% polyacrylamide gels (19) to determine the purity of each fraction and were subjected to Western blot analysis as described above. The L7/L12 protein was also isolated from Brucellergen (batch 96 G 091; Rhone-Merieux, Lyon, France) by affinity column purification and subjected to Western blot analysis in accordance with the protocols described above. In addition, immunoaffinity-purified L7/L12 was further purified by SDS-PAGE. The band corresponding to the 12-kDa protein (the L7/L12 protein as identified by Western immunoblot analysis) was excised from the gel. The resulting highly purified L7/L12 protein was released from the gel by electroelution and then dialyzed against saline. The protein concentration was determined according to the technique of Bradford (8) .
Amino acid sequencing. The purified L7/L12 protein isolated from the brucellin INRA with the affinity purification column was subjected to N-terminal amino acid sequencing by the automatic Edman degradation procedure with an Applied Biosystems 475A gas-phase protein sequencer coupled with a synchronized high-performance liquid chromatography system.
Skin reaction test. Forty male Hartley guinea pigs (250 g each at the beginning of the experiment) were sensitized by subcutaneous injection of 106 B. melitensis Revl organisms per animal (1). Three weeks later, recombinant L7/L12, affinitypurified L7/L12, Brucellergen (Rhone-Merieux), and L7/L12-depleted Brucellergen were injected intradermally at various doses (in 100 RI). The L7/L12 protein (150 ng) purified on the immunoaffinity column and then subjected to SDS-PAGE and electroelution was injected into three sensitized guinea pigs and one control guinea pig. Diameters (in millimeters) of the areas of erythema were read 24 h later. The immediate nonspecific response was checked after 4 h.
The statistical analysis was done by the SAS (1990) generalized linear models procedure.
RESULTS
Antigenicity of the B. melitensis L7/L12 protein expressed in E. coli. The DNA of B. melitensis 16M encoding the L7/L12 protein was amplified by PCR with the primers p512 and p312. The resulting product had a size of 375 bp (data not shown), compatible with the expected size of the gene. It was subcloned in plasmid pQE30 to give plasmid pQE3012, which subsequently was transformed into E. coli SG13009. The six histidines tagged at the N terminus of the recombinant protein enabled purification of the product with the Ni-NTA column. As can be seen in Fig. 1 (lane b) , the recombinant protein was expressed in E. coli at a high level (8 mg of recombinant protein per liter of E. coli culture) and was purified to complete homogeneity (6 mg of pure recombinant protein per liter of bacterial culture) by passage of the E. coli lysate through the Ni-NTA column (Fig. 1, lanes d to h) Fig. 2  (lanes b and d, respectively) , it was highly specific and sensitive for the detection of the L7/L12 protein.
Identification and purification of L7/L12 from Brucellergen and brucella lysate. Brucella L7/L12 protein was purified from Brucellergen and from the B. melitensis B115 lysates with the rabbit antibodies bound to the Affi-Gel column. Figure 3 depicts the various stages of purification of the protein from Brucellergen. Purification from whole-cell lysates produced the same results (data not shown). A single protein band was obtained after elution of the column and was subjected to N-terminal amino acid sequencing for definitive identification. The resulting sequence confirmed that this protein was the L7/L12 protein; the sequence was identical for the first 9 amino acids (ADLAKIVED) to the amino acid sequences deduced Analysis of rabbit anti-L7/L12 serum specificity. A rabbit was immunized with the purified recombinant brucella L7/L12 protein (see the legend to Fig. 1). Brucellergen (lanes a and b) from the L7/L12 B. melitensis and B. abortus DNA sequences. It was also identical to the N-terminal amino acid sequence of the 12-kDa immunodominant protein (10) .
Activity of the ribosomal L7/L12 protein in sensitized guinea pigs. The antigenicity of the various preparations of the L7/L12 ribosomal protein in the DTH reaction was compared with that of Brucellergen. The sensitization of guinea pigs inoculated with live B. melitensis Revl was checked 3 weeks after inoculation with Brucellergen. A typical reaction in these guinea pigs, which were injected with a 1-to-15 dilution of Brucellergen (7 ,ug of protein in 100 ,ll), was an area of erythema with a mean diameter of 19 mm. As shown in Fig. 4 , further dilutions of Brucellergen led to reductions in the sizes of the areas of erythema. The regression of the sizes of the areas of erythema on log (dose) calculated from the results up to the dose of 2 ,ug was not significant (P = 0.1367). One outlying result (an area of erythema with a diameter of 24.5 mm after a protein dose of 0.41 ,ug) was excluded from the calculation.
Doses of 16 and 6 jig of the recombinant L7/L12 protein produced in E. coli and purified with the Ni-NTA column (as described above) were intradermally injected into five guinea pigs sensitized to B. melitensis and into two naive control guinea pigs. No detectable DTH reaction to the recombinant protein was observed in sensitized guinea pigs, whereas the same guinea pigs reacted to Brucellergen injected into the contralateral side, as described above.
B. melitensis L7/L12 proteins purified from either Brucellergen or whole-cell brucella lysate as described above were intradermally injected into sensitized guinea pigs. As can be seen in Fig. 4 , the L7/L12 protein purified from Brucellergen elicited a strong DTH response at amounts as small as 62.5 ng. The DTH response of the guinea pigs to the L7/L12 protein was dose dependent up to the 1-,ug dose (P = 0.0001), with a slope much steeper than that obtained for Brucellergen. The result obtained with 2 jig of the L7/L12 protein was not included. The 500-ng dose of L7/L12 gave a reaction similar to that for 2,500 ng of Brucellergen, demonstrating that the L7/L12 protein was a potent DTH-revealing antigen. Similar results (data not shown) were obtained with the L7/L12 protein isolated from whole-cell brucella lysate. The injection of the L7/L12 protein (150 ng) purified by immunoaffinity and then subjected to SDS-PAGE and electroelution resulted also in a significant DTH reaction (erythema areas with diameters of 10 mm ± 1 mm versus no reaction in the control guinea pig). In order to evaluate the relative activity of the L7/L12 protein in Brucellergen, whole Brucellergen and Brucellergen from which the L7/L12 has been depleted by the affinity column method were intradermally injected into sensitized guinea pigs. Depletion of the L7/L12 antigen from Brucellergen resulted in a reduction of the allergenic activity of the preparation. A significant regression on log (dose) was demonstrated (P = 0.038). There was no significant difference between the slopes (P = 0.817) of the lines of the two preparations (regular or depleted Brucellergen). Therefore, a model with a common slope (P = 0.011) was adopted, and the lines in Fig. 4 (16, 20, 25, (31) (32) (33) (34) . It has been shown that brucella (11) and mycobacterium (3, 4, 23) ribosomes can elicit a DTH response when injected into sensitized animals. However, what exactly in the ribosomes induced the DTH was not definitively identified. The results reported in our present work clearly identify brucella ribosomal protein L7/L12 as an antigen capable of eliciting DTH in brucella-sensitized guinea pigs. We showed that this protein is present in Brucellergen (Fig. 2) It has been suggested that the immunological properties of ribosomal proteins depend on contaminating molecules such as rRNA or cellular RNA (11) . The purified B. melitensis L7/L12 protein was treated with RNase (500 ng of L7/L12 in 0.1 ml with 5 mg of RNase for 1 h at 37°C) (data not shown), and it did not lose its DTH activity after treatment. In contrast, the DTH reaction was nearly nullified when the L7/L12 protein was treated with proteinase K (500 ng of L7/L12 in 0.1 ml with 5,ug of proteinase K for 1 h at 50°C, followed by inactivation at 80°C for 10 min). The 
